HomeInsightsResults

Aarti Drugs Ltd Quarterly Result

Aarti Drugs Ltd Quarterly Result

stocks purchased

₹ 0.5 Cr

Volume Transacted

(Dec 20, 2024)

stocks purchased

12.6 K

Stocks Traded

(Dec 20, 2024)

Last Updated on: Dec 22, 2024

Image

Aarti Drugs Ltd

NSE: AARTIDRUGS

Net Profit

₹ 34.96

Last updated on: Dec 22, 2024

Key Highlights

  • The revenue of Aarti Drugs Ltd for the Sep '24 is ₹ 599.81 crore as compare to the Jun '24 revenue of ₹ 556.45 crore. This represent the growth of 7.7922516%.
  • The ebitda of Aarti Drugs Ltd for the Sep '24 is ₹ 68.53 crore as compare to the Jun '24 ebitda of ₹ 66.07 crore. This represent the growth of 3.7233224%.
  • The net profit of Aarti Drugs Ltd for the Sep '24 is ₹ 34.96 crore as compare to the Jun '24 net profit of ₹ 33.27 crore. This represent the growth of 5.079647%.

Results Analysis

Market Price of Aarti Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Aarti Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Dec 2024427.65
19 Dec 2024431.9
18 Dec 2024433.2
17 Dec 2024436.7
16 Dec 2024443.9
13 Dec 2024444.95
12 Dec 2024446.05
11 Dec 2024453.75
10 Dec 2024444.7
09 Dec 2024455.55

Historical Revenue of Aarti Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Aarti Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Aarti Drugs Ltd

No data available

* All values are in crore

Aarti Drugs Ltd News Hub

News

Aarti Drugs to conduct board meeting

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 24 October 202...

Read more

18 Oct 2024 10:48

News

Aarti Drugs gains after arm receives UK MHRA GMP Compliance Certificate

The company said that there are no financial or material impacts as of now. With the GMP c...

Read more

04 Oct 2024 11:09

News

Aarti Drugs' Maharashtra facility gets 7 observations from USFDA

The API inspection was conducted from 12 September to 20 September 2024. At the conclusion...

Read more

21 Sep 2024 14:05

News

Aarti Drugs extends buyback offer period

Aarti Drugs announced that the bidding process of buyback offer will remain open on Monday...

Read more

16 Sep 2024 08:52

News

Aarti Drugs AGM scheduled

Aarti Drugs announced that the Annual General Meeting (AGM) of the company will be held on...

Read more

03 Sep 2024 11:38

News

Board of Aarti Drugs approves buyback of shares up to Rs 59.85 cr

The Board of Aarti Drugs at its meeting held on 26 August 2024 has approved buyback of up ...

Read more

26 Aug 2024 17:17

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Aarti Drugs Ltd

What key financial metrics are included in Aarti Drugs Ltd's quarterly results?

Key financial metrics in Aarti Drugs Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Aarti Drugs Ltd announce its quarterly results?

Aarti Drugs Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Aarti Drugs Ltd's quarterly performance impact its stock price?

Aarti Drugs Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Aarti Drugs Ltd's quarterly results on dividends?

The impact of Aarti Drugs Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Aarti Drugs Ltd's quarterly results?

Yes, Aarti Drugs Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions